Meghan J. Brady is a Scientific Analyst at Morrison Foerster, where she focuses on patent drafting and prosecution in areas related to plant biology, agricultural biotechnology, and genetics.

Meghan brings extensive technical expertise in molecular genetics, bioinformatics, and genome annotation. Her research background includes developing computational methods for detecting structural variants in genome sequencing data and using CRISPR/Cas9 gene editing to resolve gene function. She has hands-on experience with the agricultural product development pipeline through her work at leading agricultural biotechnology companies, where she designed bioinformatics software for genome annotation and conducted expression and pan-genomic analyses to identify genes with direct application to crop improvement.

Before joining Morrison Foerster, Meghan worked in the agricultural biotechnology sector, where she developed and deployed a fully automated genome annotation pipeline and gained comprehensive insight into the research-to-product process in agricultural innovation. She also gained exposure to regulatory frameworks relevant to agricultural biotechnology through instruction with regulatory affairs leadership.

Meghan earned her Ph.D. in Genetics from the University of Georgia and holds a B.S. in Biology and Environmental Studies from Gettysburg College.